戴志松, 陈堃, 林淑芳, 周银发, 郑奎城, 魏淑贞. 福建省成功治疗的肺结核患者10年复发情况及影响因素分析[J]. 疾病监测, 2021, 36(11): 1152-1158. DOI: 10.3784/jbjc.202106300378
引用本文: 戴志松, 陈堃, 林淑芳, 周银发, 郑奎城, 魏淑贞. 福建省成功治疗的肺结核患者10年复发情况及影响因素分析[J]. 疾病监测, 2021, 36(11): 1152-1158. DOI: 10.3784/jbjc.202106300378
Dai Zhisong, Chen Kun, Lin Shufang, Zhou Yinfa, Zheng Kuicheng, Wei Shuzhen. Ten-year recurrence rate in pulmonary tuberculosis patients after successful treatment and influencing factors in Fujian[J]. Disease Surveillance, 2021, 36(11): 1152-1158. DOI: 10.3784/jbjc.202106300378
Citation: Dai Zhisong, Chen Kun, Lin Shufang, Zhou Yinfa, Zheng Kuicheng, Wei Shuzhen. Ten-year recurrence rate in pulmonary tuberculosis patients after successful treatment and influencing factors in Fujian[J]. Disease Surveillance, 2021, 36(11): 1152-1158. DOI: 10.3784/jbjc.202106300378

福建省成功治疗的肺结核患者10年复发情况及影响因素分析

Ten-year recurrence rate in pulmonary tuberculosis patients after successful treatment and influencing factors in Fujian

  • 摘要:
      目的  分析福建省成功治疗的肺结核患者在10年内的复发情况及其影响因素,为结核病防控工作提供参考。
      方法  通过“中国疾病预防控制信息系统”收集2010 — 2020年福建省登记的肺结核患者资料,计算2010年登记并成功治疗的肺结核患者10年复发率,采用多因素Cox比例风险回归模型分析复发的影响因素。
      结果  纳入的18 367例成功治疗肺结核患者中,10年内复发219例,复发率为0.12/100人年。 中位复发间隔时间为47.40个月。 多因素Cox比例风险回归分析结果显示,男性[风险比(HR)=1.87,95%置信区间(CI):1.31~2.68]、户籍地为本地(HR=1.60,95%CI:1.07~2.39)、就诊延误>14 d(HR=1.37,95%CI:1.03~1.82)、首诊单位为结核专科医院及其他医院(HR=3.06,95%CI:2.13~4.39;HR=1.66,95%CI:1.09~2.53)和复治(HR=1.76,95%CI:1.17~2.65)是成功治疗的肺结核患者复发的危险因素。
      结论  福建省成功治疗的肺结核患者10年内复发率为0.12/100人年,男性、户籍地为本地、涂片阳性、就诊延误>14 d、首诊单位为结核专科医院或其他医院和复治的成功治疗肺结核患者复发风险较高。

     

    Abstract:
      Objective  To analyze the 10-year recurrence in pulmonary tuberculosis (TB) patients after successful treatment in Fujian province and provide evidence for TB prevention and control.
      Methods  The data of pulmonary TB patients during 2010–2020 in Fujian were collected from China Disease Prevention and Control Information System. The 10-year recurrence rate were calculated, and the influencing factors were analyzed by a Cox proportional hazard regression model.
      Results  Among the 18 367 cured pulmonary TB patients surveyed in Fujian, 219 relapsed within 10 years. The recurrence rate was 0.12/100 person-years and the median of recurrence interval was 47.40 months. Multivariate Cox proportional hazard regression analysis showed that being male (Hazard ratio, HR=1.87, 95% CI: 1.31–2.68), local registered residence (HR=1.60, 95% CI: 1.07–2.39), medical care seeking delay >14 days (HR=1.37, 95% CI: 1.03–1.82), first diagnosis in special TB hospital and other hospital (HR=3.06, 95% CI: 2.13–4.39; HR=1.66, 95% CI: 1.09–2.53), retreatment (HR=1.76, 95% CI: 1.17–2.65) were the major risk factors for the recurrence in the cured pulmonary TB patients.
      Conclusion  The 10-year recurrence rate of pulmonary TB patients was 0.12/100 person-years in Fujian. Cured TB patients who were male, local residents, smear-positive, retreated patients and had medical care seeking delay >14 days and first diagnosis in special TB hospital or other hospital had higher risk for recurrence.

     

/

返回文章
返回